fda banned tirzepatide says compounding pharmacies can keep making weight-loss med tirzepatide, for now FDA moves to remove GLP-1

Pharmacoeconomic Review Report: Semaglutide (Ozempic): (Novo Nordisk Canada Inc.): Indication: For the treatment of adults patients with type 2 diabetes mellitus to improve glycemic control, in combination with metformin (second-line treatment), and in combination with metformin and sulfonylurea (third-line treatment) [Internet]

9 , eaal3604 (2017)

GHK-Cu powder (lyophilized) maintains potency 12-24 months frozen, 6-12 months refrigerated, or just 2-3 months at room temperature , with vacuum-sealed containers and desiccant packets extending these timelines

Ozempic (semaglutide) is an FDA-approved GLP-1 receptor agonist that mimics a hormone naturally produced in your gut

The quality was excellent, and shipping was fast